John Doe M.D.
Here is a summarized and professionally formatted version of the affidavit from the fictitious John Doe, M.D., maintaining its original meaning while highlighting the key points and legal implications:
Affidavit Summary: John Doe, M.D. (Fictitious Name)
Location: Washington, D.C.
Date: Circa 1978
Subject: Medical Assessment and Treatment Plan for Robert C. Randall
Qualifications & Background
Dr. John Doe is a board-certified ophthalmologist with extensive training and professional experience:
Medical Degree: Howard University College of Medicine, 1968
Internship: USC Medical Center, Los Angeles (1968–1969)
Residency in Ophthalmology: Completed in 1972
Private Practice (Washington, D.C.): 1972–1974; resumed in 1976
Federal Medical Officer (1972–1974): Served in ophthalmology for HEW, PHS, and FDA
Fellowship (1974–1976): Cornea and External Disease, Massachusetts Eye and Ear Infirmary
Patient Involvement
Dr. Doe began treating Robert Randall on or about March 20, 1978.
He received an oral patient history and treatment overview from Randall’s former physician, Dr. John Merritt, pending full record transfer.
Dr. Doe confirmed that no contradictory findings were discovered during his own examination of Randall.
Assessment and Treatment Recommendation
Based on:
The oral clinical history provided by Dr. Merritt
Direct examination and interview with Randall
The presumption of legal access to all treatment substances
Dr. Doe affirms that he would prescribe the following continuation of the established regimen, if legally permitted:
Glaucon 2% (twice daily)
Phospholine Iodide 0.06% (twice daily)
6 to 10 marijuana cigarettes per day (0.9 grams each, THC content 2–3%)
Dr. Doe further emphasizes that:
He reserves clinical judgment to adjust or discontinue treatment based on ongoing evaluation or patient risk.
Legal and Clinical Significance
This affidavit reinforces:
Continuity of care between physicians using cannabis as a medically necessary treatment
The efficacy of cannabis in managing Randall’s chronic open-angle glaucoma
A professional endorsement of cannabis as part of a rational treatment protocol—conditioned on legal authorization
